NYSE Content Update: Versigent To Ring Opening Bell As its Shares Debut for Trade
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK,…
NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES / ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
Ghent, Belgium, March 26, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE REGULATED INFORMATION…
LECTRA : Monthly declaration of the total number of shares and voting rights composing the company’s capital (at February 28th,2026)
Monthly declaration of the total number of shares and voting rights composing…
Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares
February 20, 2026 16:49 ET | Source: Bel Fuse Inc. WEST ORANGE,…
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
DUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB),…
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Company Announcement COPENHAGEN, Denmark; February 20, 2026 – Genmab A/S (Nasdaq: GMAB)…
Ipsen – January 2026 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares…
VALNEVA Declaration of shares and voting rights: January 31, 2026
VALNEVA Declaration of shares and voting rights January 31, 2026__________________________________________________________________________________________ Company name:…
NYSE Content Advisory: Pre-Market update + AstraZeneca Shares Begin Trading on NYSE in Record Transfer
NEW YORK, Feb. 2, 2026 /PRNewswire/ -- The New York Stock Exchange…
Mandira Bedi Shares Her Journey of Resilience, Discipline and Reinvention on the New Episode of Herbalife India’s Podcast Live Your Best Life, Unscripted
BENGALURU, India, Jan. 27, 2026 /PRNewswire/ -- Herbalife India has released a compelling…
